Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

SANUWAVE Health (SNWV) Preferred Shares Issued (2020)

SANUWAVE Health (SNWV) reported Preferred Shares Issued of $200000.0 for Q2 2020, down 91.11% on a QoQ basis from $2.2 million in Q1 2020.

SANUWAVE Health (SNWV) has 1 years of Preferred Shares Issued data on file, last reported at $200000.0 in Q2 2020.

  • Quarterly Preferred Shares Issued changed N/A year-over-year to $200000.0 in Q2 2020, while the trailing twelve-month figure through Mar 2021 was $200000.0 (down 91.11% YoY) and the FY2020 annual result came in at $2.4 million, changed N/A from the prior year.
  • Preferred Shares Issued fell to $200000.0 in Q2 2020 per SNWV's latest filing, from $2.2 million in the prior quarter.
  • Across five years, Preferred Shares Issued topped out at $2.2 million in Q1 2020 and bottomed at $200000.0 in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares Issued (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -
10 SANUWAVE Health 137.37 Mn 126.59 Mn 7.43 Mn -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2020 200,000.00
Jun 30, 2020 200,000.00
Mar 31, 2020 2.25 Mn
Mar 31, 2020 2.25 Mn